‘Our spark has gone’: The marriages ruined by Ozempic
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"‘Our spark has gone’: The marriages ruined by Ozempic" is generating significant coverage in the Health category, with 3 articles from 3 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Medical Xpress, University of Chicago News and The Telegraph. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 105d ago.
Quick answers
Why is "‘Our spark has gone’: The marriages ruined by Ozempic" trending?
Because 3 independent news sources published 3 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (3)
- GLP-1 drugs may hold few benefits beyond physical health, study finds Medical Xpress · 108d ago
- GLP-1 drugs may hold few benefits beyond physical health, study finds University of Chicago News · 108d ago
- ‘Our spark has gone’: The marriages ruined by Ozempic The Telegraph · 108d ago
Topics
Related trends
The Offshore Wind Industry Gave Him the Well-Paying Work He Needed. Then Trump Gutted It.
Federal actions and policy shifts under Trump have severely impacted the United States offshore wind sector, threatening jobs and investments.
The Fed chief said AI would tame inflation. His colleagues disagree.
Federal Reserve officials are publicly divided over whether artificial intelligence infrastructure is driving or taming inflation.
Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns
Internal medicine physician Dr. Frank Dumont warns that stopping GLP-1 medications like Ozempic and Zepbound carries six rebound risks, including rapid weight regain, loss of cardiovascular protection, and worsening mental health.
Here's Why The Dire Wolf Really Wasn't Brought Back From Extinction, Scientists Argue
Scientists push back on claims that dire wolves have been resurrected, arguing the animals are genetically modified gray wolves, not true de-extinction.
The Archbishop of San Francisco on Staying Human in the AI Age
Pope Leo XIV's new AI encyclical sparks global Catholic dialogue as tech workers and theologians debate human dignity in the algorithmic age.
FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
Federal regulators mandate new vision loss warning labels across the widely used GLP-1 receptor agonist drug class.